Measures after cabozantinib resistance

Cabozantinib, as a multi-target tyrosine kinase inhibitor, plays an important role in cancer treatment. However, after long-term use, some patients may develop drug resistance. Faced with this situation, doctors and patients can take a series of measures to deal with it.

When resistance to cabozantinib occurs, doctors will first consider adjusting the medication regimen. This may include increasing the dose of the medication or switching to another medication. According to some studies, the dose of cabozantinib can be appropriately increased after drug resistance, but should not exceed the recommended maximum dose of 80 mg per day.

Combination therapy is another effective strategy to overcome drug resistance. Cabozantinib can be used in combination with other drugs to enhance its anti-tumor effect. For example, studies have shown that combining cabozantinib with immunotherapy or other targeted drugs may produce better therapeutic effects.

For patients who develop local progression or metastasis, local therapy such as radiotherapy or surgery may be an effective option. This can help control local symptoms of the disease and potentially extend patient survival.

For patients who don't respond to standard treatments, participating in a clinical trial may be a good option. Clinical trials often provide the latest treatment options and may provide better outcomes for patients.

During treatment, continued monitoring of the patient's condition and drug response is critical. Through regular imaging examinations, blood tests, etc., doctors can keep abreast of changes in the patient's condition and adjust treatment plans accordingly.

In addition to drug treatment, patients should also pay attention to maintaining a good lifestyle, including a reasonable diet, moderate exercise, and adequate rest. At the same time, psychological support is also important because the cancer treatment process can cause great psychological stress to patients.